Home/Filings/4/0001225208-25-001793
4//SEC Filing

Mirviss Jeffrey B. 4

Accession 0001225208-25-001793

CIK 0000885725other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:29 PM ET

Size

8.2 KB

Accession

0001225208-25-001793

Insider Transaction Report

Form 4
Period: 2025-02-12
Mirviss Jeffrey B.
SVP&Pres, Periph Intervent
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-12+2,11530,569 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-122,1156,347 total
    Exp: 2028-02-12Common Stock (2,115 underlying)
  • Tax Payment

    Common Stock

    2025-02-12$105.77/sh868$91,80829,701 total
Footnotes (2)
  • [F1]Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
  • [F2]Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.

Documents

1 file

Issuer

BOSTON SCIENTIFIC CORP

CIK 0000885725

Entity typeother

Related Parties

1
  • filerCIK 0001566094

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:29 PM ET
Size
8.2 KB